Wells Fargo Maintains Overweight on Medtronic, Raises Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen maintains an Overweight rating on Medtronic (NYSE:MDT) and raises the price target from $102 to $105.
May 24, 2024 | 2:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst Larry Biegelsen maintains an Overweight rating on Medtronic and raises the price target from $102 to $105.
The raised price target and maintained Overweight rating from a reputable analyst at Wells Fargo is likely to positively impact Medtronic's stock price in the short term as it signals confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100